The Role of Hysterolaparoscopy in Infertile Patients With Normal Hysterosalpingography
Launched by CAIRO UNIVERSITY · Apr 4, 2017
Trial Information
Current as of May 17, 2025
Unknown status
Keywords
ClinConnect Summary
The hysteroscopy used was rigid continuous flow diagnostic hysteroscopy (Tuttligen, Karl Storz, Germany). It has a 30o panoramic optic which is 4mm in diameter and the diagnostic continuous flow outer sheath is 6.5 mm in diameter.
The patient was placed in lithotomy position with the buttocks projecting slightly beyond the table edge. The perineum and vagina were gently swabbed with povidone-iodine. The cervix was exposed was exposed with a posterior wall retractor and a tenaculum was applied to its anterior lip. The telescope was inserted into the sheath then flushed with distension media...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Primary infertility defined as failure to conceive after one year of unprotected sexual intercourse
- • 2. No detectable pelvic pathology based on history, physical examination and trans-vaginal ultrasound
- • 3. Previous received treatment of six or more cycles in the form of ovulation stimulation
- • 4. Normal HSG
- Exclusion Criteria:
- • 1. Couples with male factor infertility
- • 2. Sexual problems
- • 3. Contraindications to laparoscopy
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Ahmed Maged, MD
Principal Investigator
Kasr Alainy medical school
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials